|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01526 RICI HEALTH
Nominal 
1.200 0.000 (0.000%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 7.905% | 6.389% | 4.151% | -0.190% | -2.150% |
| ROAE (%) | 34.967% | 35.649% | 30.686% | -1.370% | -10.333% |
| Return on Capital Employed (%) | 14.714% | 12.051% | 7.244% | -0.348% | -2.930% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 41.752% | 39.040% | 35.871% | 30.161% | 28.037% |
| EBITDA Margin (%) | 35.211% | 32.525% | 30.636% | 23.235% | 19.034% |
| Pre-tax Profit Margin (%) | 18.232% | 13.776% | 9.075% | -5.653% | -9.747% |
| Net Profit Margin (%) | 12.156% | 12.244% | 7.243% | -0.409% | -4.007% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 0.664 X | 0.630 X | 0.710 X | 0.621 X | 0.616 X |
| Quick Ratio (X) | 0.647 X | 0.612 X | 0.685 X | 0.598 X | 0.590 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 75.979% | 80.187% | 87.050% | 92.105% | 86.171% |
| Total Debt / Total Assets (%) | 48.872% | 50.331% | 60.476% | 68.948% | 65.367% |
| Net Debt / Total Assets (%) | 31.380% | 34.562% | 43.473% | 55.606% | 57.272% |
| Total Debt / Shareholders' Funds (%) | 201.123% | 240.959% | 404.915% | 574.012% | 413.022% |
| Long Term Debt / Shareholders' Funds (%) | 120.218% | 148.637% | 247.844% | 356.547% | 259.091% |
| Net Debt / Shareholders' Funds (%) | 129.140% | 165.466% | 291.075% | 462.939% | 361.868% |
| Net Cash / (Debt) ($) | (1.455B) | (1.578B) | (1.972B) | (2.342B) | (2.331B) |
| Net Cash / (Debt) per share ($) | (0.915) | (0.993) | (1.240) | (1.472) | (1.466) |
| Total Debt / Capital Employed (%) | 91.669% | 95.257% | 109.464% | 128.142% | 112.732% |
| Interest Coverage Ratio (X) | 5.292 X | 3.659 X | 2.466 X | 0.351 X | N/A |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 7.970 Day | 11.309 Day | 10.753 Day | 11.958 Day | 11.121 Day |
| Receivables Turnover (Day) | 35.259 Day | 48.059 Day | 45.825 Day | 54.288 Day | 59.073 Day |
| Payables Turnover (Day) | 20.440 Day | 27.663 Day | 25.671 Day | 28.970 Day | 29.468 Day |
| Remarks: | Real time quote last updated: 11/11/2024 10:06 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 84,991 |
| %Change | -31.109% |
| EPS / (LPS) | RMB 0.050 |
| NBV Per Share (¥) | RMB 0.762 |